Krystal Biotech Inc

XNAS:KRYS

375.07

+3.49 (+0.94%)

7:38:41 PM EDT: $378.28 +3.21 (+0.86%)

Market Cap (Intraday)	11.16B
Current PE	49.60
Forward PE	48.9
2yr Forward PE	38.71

See more stats

Estimates Current Quarter

Revenue	$123.83 Million
Adjusted EPS	$1.77

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Krystal Biotech Inc Stock, XNAS:KRYS

2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203

United States of America

Phone: +1.412.586.5830

Number of Employees: 275

http://www.krystalbio.com

Description

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.